Aprepitant Capsules and Methylphenidate Extended-Release Tablets
Determining the interaction of Aprepitant Capsules and Methylphenidate Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Methylphenidate Hydrochloride
- Aprepitant Capsules-Methylphenidate LA Capsules
- Aprepitant Capsules-Methylphenidate Oral Solution
- Aprepitant Capsules-Methylphenidate Oral, Transdermal
- Aprepitant Capsules-Methylphenidate Tablets
- Aprepitant Capsules-Methylphenidate transdermal
- Methylphenidate Extended-Release Tablets-Aprepitant Injection
- Methylphenidate Extended-Release Tablets-Aprepitant Intravenous
- Methylphenidate Extended-Release Tablets-Aprepitant Oral Suspension
- Methylphenidate Extended-Release Tablets-Aprepitant/Fosaprepitant Dimeglumine
- Methylphenidate Extended-Release Tablets-Apresazide
- Methylphenidate Extended-Release Tablets-Apresoline